160 related articles for article (PubMed ID: 33905626)
21. Transforming growth factor-β1 gene promoter -509C/T polymorphism in association with expression affects colorectal cancer development and depends on gender.
Stanilova S; Stanilov N; Julianov A; Manolova I; Miteva L
PLoS One; 2018; 13(8):e0201775. PubMed ID: 30071009
[TBL] [Abstract][Full Text] [Related]
22. Investigating the mechanisms of papillary thyroid carcinoma using transcriptome analysis.
Qiu J; Zhang W; Xia Q; Liu F; Zhao S; Zhang K; Chen M; Zang C; Ge R; Liang D; Sun Y
Mol Med Rep; 2017 Nov; 16(5):5954-5964. PubMed ID: 28849102
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of insulin-like growth factor II, cyclooxygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumours.
Fuhrer D; Eszlinger M; Karger S; Krause K; Engelhardt C; Hasenclever D; Dralle H; Paschke R
Eur J Endocrinol; 2005 May; 152(5):785-90. PubMed ID: 15879365
[TBL] [Abstract][Full Text] [Related]
24. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
25. mRNA BRAF expression helps to identify papillary thyroid carcinomas in thyroid nodules independently of the presence of BRAFV600E mutation.
Araujo PP; Marcello MA; Tincani AJ; Guilhen AC; Morari EC; Ward LS
Pathol Res Pract; 2012 Aug; 208(8):489-92. PubMed ID: 22770943
[TBL] [Abstract][Full Text] [Related]
26. Differential regulation of follicle stimulating hormone by activin A and TGFB1 in murine gonadotropes.
Gore AJ; Philips DP; Miller WL; Bernard DJ
Reprod Biol Endocrinol; 2005 Dec; 3():73. PubMed ID: 16384533
[TBL] [Abstract][Full Text] [Related]
27. Mutual regulation of TGF-β1, TβRII and ErbB receptors expression in human thyroid carcinomas.
Mincione G; Tarantelli C; Vianale G; Di Marcantonio MC; Cotellese R; Francomano F; Di Nicola M; Costantini E; Cichella A; Muraro R
Exp Cell Res; 2014 Sep; 327(1):24-36. PubMed ID: 24973511
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional activity of TGFβ1 and its receptors genes in thyroid gland.
Kajdaniuk D; Marek A; Marek B; Mazurek U; Fila-Daniłow A; Foltyn W; Morawiec-Szymonik E; Siemińśka L; Nowak M; Głogowska-Szeląg J; Niedziołka-Zielonka D; Seemann M; Kos-Kudła B
Endokrynol Pol; 2016; 67(4):375-82. PubMed ID: 27345036
[TBL] [Abstract][Full Text] [Related]
29. Notch and TGF-β/Smad3 pathways are involved in the interaction between cancer cells and cancer-associated fibroblasts in papillary thyroid carcinoma.
Zhang J; Wang Y; Li D; Jing S
Tumour Biol; 2014 Jan; 35(1):379-85. PubMed ID: 23918305
[TBL] [Abstract][Full Text] [Related]
30. Association of the TGF-beta receptor genes with abdominal aortic aneurysm.
Baas AF; Medic J; van 't Slot R; de Kovel CG; Zhernakova A; Geelkerken RH; Kranendonk SE; van Sterkenburg SM; Grobbee DE; Boll AP; Wijmenga C; Blankensteijn JD; Ruigrok YM
Eur J Hum Genet; 2010 Feb; 18(2):240-4. PubMed ID: 19672284
[TBL] [Abstract][Full Text] [Related]
31. Concordant promoter methylation of transforming growth factor-beta receptor types I and II occurs early in esophageal squamous cell carcinoma.
Dong Z; Guo W; Guo Y; Kuang G; Yang Z
Am J Med Sci; 2012 May; 343(5):375-81. PubMed ID: 22314103
[TBL] [Abstract][Full Text] [Related]
32. Solute carrier family 35 member F2 is indispensable for papillary thyroid carcinoma progression through activation of transforming growth factor-β type I receptor/apoptosis signal-regulating kinase 1/mitogen-activated protein kinase signaling axis.
He J; Jin Y; Zhou M; Li X; Chen W; Wang Y; Gu S; Cao Y; Chu C; Liu X; Zou Q
Cancer Sci; 2018 Mar; 109(3):642-655. PubMed ID: 29274137
[TBL] [Abstract][Full Text] [Related]
33. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules.
Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L
Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935
[TBL] [Abstract][Full Text] [Related]
34. Single-nucleotide variants in TGFB1, TGFBR2, IL17A, and IL17F immune response genes contribute to follicular lymphoma susceptibility and aggressiveness.
Assis-Mendonça GR; Lourenço GJ; Delamain MT; de Lima VCC; Colleoni GWB; de Souza CA; Soares FA; Lima CSP; Vassallo J
Blood Cancer J; 2020 Oct; 10(10):97. PubMed ID: 33024088
[No Abstract] [Full Text] [Related]
35. Genetic association and gene expression profiles of TGFB1 and the contribution of TGFB1 to otosclerosis susceptibility.
Priyadarshi S; Ray CS; Panda KC; Desai A; Nayak SR; Biswal NC; Ramchander PV
J Bone Miner Res; 2013 Dec; 28(12):2490-7. PubMed ID: 23703862
[TBL] [Abstract][Full Text] [Related]
36. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
Dong G; Zhang R; Xu J; Guo Y
Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
[TBL] [Abstract][Full Text] [Related]
37. Methylation markers differentiate thyroid cancer from benign nodules.
Stephen JK; Chen KM; Merritt J; Chitale D; Divine G; Worsham MJ
J Endocrinol Invest; 2018 Feb; 41(2):163-170. PubMed ID: 28612287
[TBL] [Abstract][Full Text] [Related]
38. Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma.
Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G
Mol Biol Rep; 2012 Apr; 39(4):4301-9. PubMed ID: 21785915
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic utility of DREAM gene mRNA levels in thyroid tumours.
Batista FA; Marcello MA; Martins MB; Peres KC; Cardoso UO; Silva ACDN; Bufalo NE; Soares FA; Silva MJD; Assumpção LV; Ward LS
Arch Endocrinol Metab; 2018; 62(2):205-211. PubMed ID: 29641740
[TBL] [Abstract][Full Text] [Related]
40. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules.
Finley DJ; Arora N; Zhu B; Gallagher L; Fahey TJ
J Clin Endocrinol Metab; 2004 Jul; 89(7):3214-23. PubMed ID: 15240595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
